ES8800040A1 - Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.

Info

Publication number
ES8800040A1
ES8800040A1 ES551635A ES551635A ES8800040A1 ES 8800040 A1 ES8800040 A1 ES 8800040A1 ES 551635 A ES551635 A ES 551635A ES 551635 A ES551635 A ES 551635A ES 8800040 A1 ES8800040 A1 ES 8800040A1
Authority
ES
Spain
Prior art keywords
pharmaceutical
ergot alkaloid
containing compositions
dihydroergotamine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551635A
Other languages
English (en)
Other versions
ES551635A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES551635A0 publication Critical patent/ES551635A0/es
Publication of ES8800040A1 publication Critical patent/ES8800040A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA OBTENER UNA COMPOSICION FARMACEUTICAMENTE DE LIBERACION RETARDADA DE 9,10-HIDRIDRO-ALCALOIDES. COMPRENDE: A) COMBINAR A (A) CON (B), ENTRE 30 Y 90GC Y EN UNA PROPORCION EN PESO DE A/B DE 1:0,5 A 1:10; B) SOLIDIFICAR LA COMBINACION FORMADA; C) ENFRIAR LA COMBINACION SOLIDIFICADA HASTA LA TEMPERATURA AMBIENTE; D) GRANULAR LA COMBINACION ENFRIADA A TEMPERATURA AMBIENTE; E) COMBINAR A LOS GRANULOS DE MASA CON UNA SUSTANCIA (C) EN UNA PORCION EN PESO DE (A+B)/(C) DE 1:4 A 1:50, PARA OBTENER DICHA COMPOSICION FARMACEUTICA. SIENDO: (A), UN 9,10--DIHIDRO-ALCALOIDE; (B), UNA MATERIA GRASA ELEGIDA ENTRE LOS ESTERES DE ACIDOS GRASOS COMO PALMITATO DE CETILO O LOS GLICERIDOS (DIPALMITATO ESTEARATO DE GLICEROL); Y (C), UNA SUSTANCIA HIDROFILA E HINCHABLE TAL COMO HIDROCOLOIDE DE CELULOSA (HIDROXIPROPILMETIL-CELULOSA). SE UTILIZA PARA EL TRATAMIENTO DE ATAQUES DE JAQUECA AGUDA RELACIONADA CON CEFALAGIA VASCULAR. O
ES551635A 1985-02-05 1986-02-04 Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. Expired ES8800040A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (2)

Publication Number Publication Date
ES551635A0 ES551635A0 (es) 1987-10-16
ES8800040A1 true ES8800040A1 (es) 1987-10-16

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551635A Expired ES8800040A1 (es) 1985-02-05 1986-02-04 Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.

Country Status (24)

Country Link
JP (1) JPS61183225A (es)
KR (1) KR920010388B1 (es)
AU (1) AU597570B2 (es)
BE (1) BE904152A (es)
CA (1) CA1263087A (es)
CH (1) CH667592A5 (es)
CY (1) CY1604A (es)
DE (1) DE3602577A1 (es)
DK (1) DK167138B1 (es)
ES (1) ES8800040A1 (es)
FR (1) FR2576787B1 (es)
GB (1) GB2170407B (es)
GR (1) GR860310B (es)
HK (1) HK57191A (es)
HU (1) HU195729B (es)
IE (1) IE59293B1 (es)
IT (1) IT1191255B (es)
LU (1) LU86289A1 (es)
NL (1) NL8600161A (es)
NZ (1) NZ215020A (es)
PH (1) PH23384A (es)
PT (1) PT81954B (es)
SE (1) SE8600496L (es)
SG (1) SG56191G (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
RU2256454C2 (ru) * 1999-12-03 2005-07-20 Полишем С.А. Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
WO2001085163A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating eczema and/or psoriasis
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化(南京)制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ES551635A0 (es) 1987-10-16
JPS61183225A (ja) 1986-08-15
NL8600161A (nl) 1986-09-01
DK52086A (da) 1986-08-06
DE3602577A1 (de) 1986-08-28
CA1263087A (en) 1989-11-21
PH23384A (en) 1989-07-26
PT81954A (en) 1986-03-01
IT8647620A0 (it) 1986-02-05
SE8600496D0 (sv) 1986-02-04
SG56191G (en) 1991-08-23
KR860006265A (ko) 1986-09-09
HUT41984A (en) 1987-06-29
IE59293B1 (en) 1994-02-09
KR920010388B1 (ko) 1992-11-27
HK57191A (en) 1991-08-02
CY1604A (en) 1992-04-03
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
NZ215020A (en) 1989-07-27
CH667592A5 (de) 1988-10-31
GR860310B (en) 1986-05-27
IT1191255B (it) 1988-02-24
LU86289A1 (fr) 1986-09-02
FR2576787B1 (fr) 1990-01-12
IE860291L (en) 1986-08-05
DK167138B1 (da) 1993-09-06
BE904152A (fr) 1986-08-04
GB2170407B (en) 1988-10-26
DK52086D0 (da) 1986-02-03
SE8600496L (sv) 1986-08-06
AU597570B2 (en) 1990-06-07
AU5294286A (en) 1986-08-14
GB8602602D0 (en) 1986-03-12
PT81954B (pt) 1988-07-01
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
GR1003711B (el) Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν.
IE860306L (en) Drug delivery system
HRP930676B1 (en) Process for the production of an active substance plaster containing estrogen
MY118371A (en) Tetrahydrolipstatin containing compositions
CA2123321A1 (en) Combination chemotherapy
DE3379496D1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
CA2203033A1 (en) Compounds and compositions for delivering active agents
HK1004521A1 (en) Composition in the form of a foam containing 5- aminosalicylic acid for intrarectal administration
CA2179540A1 (en) Accelerated release composition containing bromocriptine
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
ES8800040A1 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
GR3023776T3 (en) Heterocyclic compounds
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
IL92797A0 (en) Therapeutical active substituted benzimidazole and process for its preparation
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
AU5673399A (en) Compositions and methods for treating intracellular infections
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
EP0572494A4 (en) Composition for use in transdermal administration
NZ229023A (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
HU9302813D0 (en) Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
EP0351876A3 (en) Composition for potentiating vaccination effect
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401